DarioHealth Corp. (DRIO)
DRIO trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1533998/000110465926031621/0001104659-26-031621-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | DRIO on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0001533998 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $22.4M |
| Net income | -$41.7M |
| Operating income | -$36.7M |
| Net margin | -186.6% |
| Operating margin | -163.9% |
| Revenue growth | -17.3% |
| Cash | $21.8M |
| Total assets | $110.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.6× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-12 |
| Cash and burn | $27.8M cash; operating cash flow -$5.9M a quarter. | Report 2026-09-30 |
| Shares outstanding | 11,287,022 (2026-11-12); 6,768,184 a year earlier; 27,214,670 three years earlier. 3y figure adjusted for split (1-for-20 overall). | Cover page 2026-11-12 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2025-08-28 | Source 2025-08-28 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-07-22 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Kesselman & Kesselman C.P.A.s, Tel-Aviv, Israel | PCAOB Form AP 2026-04-12 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $100K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $5.3M | -$8.8M | -$5.5M | $27.8M | $31.2M | $21.3M | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $5.2M | -$7.9M | -$6.1M | $6.6M | $31.1M | $21.0M | 10-Q 2026-08-11 |
| Q1 2026 2026-03-31 | $5.6M | -$8.2M | -$6.0M | $15.0M | $30.9M | $21.2M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $5.2M | -$9.0M | -$5.9M | $21.8M | $30.7M | $22.4M | 10-K 2026-03-19 |
| Q3 2025 2025-09-30 | $5.0M | -$10.5M | -$7.3M | $31.9M | $30.6M | $24.7M | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $5.4M | -$13.0M | -$6.0M | $22.0M | $30.5M | $27.1M | 10-Q 2026-08-11 |
| Q1 2025 2025-03-31 | $6.8M | -$9.2M | -$6.7M | $27.9M | $29.2M | $28.0M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $7.6M | -$9.6M | -$6.7M | $27.8M | $28.9M | $27.0M | 10-K 2026-03-19 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-22 |
| Latest annual report | 10-K | 2026-03-19 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report FORM 8-K | 8-K | 2026-11-06 |
| Latest proxy FORM DEF 14A | DEF 14A | 2025-12-22 |
Source: SEC EDGAR submissions feed, 906 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -46.9% |
| 1 month | -77.3% |
| 3 months | -82.8% |
| Year to date | -88.9% |
| 1 year | -87.3% |
| From 52-week high | -91.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GUTS | Fractyl Health Inc. | $0.9918 | +9.76% | $13.2M |
| PAVM | PAVmed Inc. | $1.75 | +7.36% | $14.0M |
| FEMY | Femasys Inc. | $1.28 | -8.57% | $11.1M |
| CTSO | Cytosorbents Corporation | $4.85 | -0.41% | $15.3M |
| SNWV | SANUWAVE Health Inc. | $1.81 | -0.55% | $15.6M |
| SINT | SiNtx Technologies Inc. | $1.34 | -1.11% | $10.1M |
| RVP | Retractable Technologies Inc. | $0.5600 | +0.02% | $16.8M |
| CVRX | CVRx Inc. | $0.6130 | +0.92% | $17.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier